Qing Lin

Title: Qing Lin: Innovator in Wireless Transmission and Cancer Treatment

Introduction

Qing Lin is a prominent inventor based in Beijing, China. He has made significant contributions to the fields of wireless communication and medical technology. With a total of 2 patents, his work reflects a commitment to advancing innovative solutions.

Latest Patents

One of Qing Lin's latest patents is titled "Adaptive frame structure for TDD point-to-point wireless transmission." This invention relates to an arrangement for point-to-point transmission over links between first and second link terminals in a system implementing time division duplex (TDD). The technology allows for the determination of frame lengths on a per link basis using various link parameters, resulting in variable frame lengths.

Another notable patent is the "Anti human ovarian cancer-anti CD3 bispecific antibody." This invention provides a bispecific antibody designed to target ovarian cancer. The antibody consists of two polypeptide domains connected by a linker, with one domain targeting ovarian cancer and the other targeting CD3. Additionally, the invention includes DNA sequences encoding the antibody, an expression vector containing the DNA sequence, and a host cell containing the expression vector.

Career Highlights

Qing Lin has worked with notable companies such as Beijing Abt Genetic Engineering Technology Co. Ltd. and Telefonaktiebolaget Lm Ericsson. His experience in these organizations has contributed to his expertise in genetic engineering and telecommunications.

Collaborations

Qing Lin has collaborated with several professionals in his field, including Hualiang Huang and Xin Jiang. These partnerships have likely enhanced his research and development efforts.

Conclusion

Qing Lin's innovative patents in wireless transmission and cancer treatment demonstrate his significant impact on technology and medicine. His work continues to inspire advancements in these critical areas.